首页> 美国卫生研究院文献>other >Efficacy and safety of Shenfu injection for patients with return of spontaneous circulation after sudden cardiac arrest
【2h】

Efficacy and safety of Shenfu injection for patients with return of spontaneous circulation after sudden cardiac arrest

机译:参附注射液对突发性心脏骤停后自发循环恢复的疗效和安全性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background:Sudden cardiac arrest (SCA) is one of the most common critical illnesses encountered in clinical practice. Shenfu injection (SFI) has received extensive attention as an alternative therapy that can effectively maintain the autonomic circulation function after cardiopulmonary resuscitation. However, the mechanism of SFI is not yet fully understood. In addition, there has been no systematic review or meta-analysis of SFI in the treatment of patients with return of spontaneous circulation after SCA. Herein, we describe the protocol of a proposed study based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines that aims to systematically evaluate the efficacy and safety of SFI in patients with return of spontaneous circulation after SCA.
机译:背景:心脏骤停(SCA)是临床实践中最常见的严重疾病之一。神甫注射液(SFI)作为一种替代疗法,可以有效地维持心肺复苏后的自主循环功能。但是,尚未完全了解SFI的机制。此外,尚无关于SFI治疗SCA后自发性循环的患者的系统评价或荟萃分析。在此,我们根据系统评价和Meta分析指南的“首选报告项目”描述了一项拟议研究的方案,旨在系统评估SCA后自发性循环的SFI的疗效和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号